NCT07461233

Modulation of Gut Microbiota Composition and Gut Permeability Profiles by Multispecies Synbiotic Supplementation in Hemodialysis Patients

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2026-05-04Est. Completion: 2026-12-31

Enrollment target: 30 participants

Locations

Tungs' Taichung Metroharbour Hospital, Taichung, Wuqi District, Taiwan

Contact

Paik Seong Lim, PhDjamespslim@gmail.com +886935045292

Other microbiome trials you might be interested in

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLCPhase 2Recruiting

CarcinomaNon-Small-Cell LungLung Cancer (NSCLC)Lung NeoplasmsCarcinoma, Non-Small-Cell Lung (NSCLC)Lung DiseaseNon-Small Cell Lung CancerNon-small Cell Lung Cancer, Non-squamousNon-small Cell Lung Cancer, Squamous

This study is being done to learn more about a new medicine called PF-08634404. The study team wants to understand how w…

Hinsdale, United StatesEst. completion Jul 29, 2028

View Trial →

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung CancerPhase 2

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.